Cargando…
Technology platform development for targeted plasma metabolites in human heart failure
BACKGROUND: Heart failure is a multifactorial disease associated with staggeringly high morbidity and motility. Recently, alterations of multiple metabolites have been implicated in heart failure; however, the lack of an effective technology platform to assess these metabolites has limited our under...
Autores principales: | Chan, CY X’avia, Khan, Anjum A, Choi, JH Howard, Ng, CM Dominic, Cadeiras, Martin, Deng, Mario, Ping, Peipei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708771/ https://www.ncbi.nlm.nih.gov/pubmed/23826926 http://dx.doi.org/10.1186/1559-0275-10-7 |
Ejemplares similares
-
Secretome Analysis of Skeletal Myogenesis Using SILAC and Shotgun Proteomics
por: Chan, C. Y. X'avia, et al.
Publicado: (2011) -
Wearable technology for early detection of COVID-19: A systematic scoping review
por: Cheong, Shing Hui Reina, et al.
Publicado: (2022) -
Anthracycline induced cardiotoxicity: biomarkers and “Omics” technology in the era of patient specific care
por: Moazeni, Shayan, et al.
Publicado: (2017) -
Comparison of Whole Blood and Peripheral Blood Mononuclear Cell Gene Expression for Evaluation of the Perioperative Inflammatory Response in Patients with Advanced Heart Failure
por: Bondar, Galyna, et al.
Publicado: (2014) -
Integrative model of leukocyte genomics and organ dysfunction in heart failure patients requiring mechanical circulatory support: a prospective observational study
por: Wisniewski, Nicholas, et al.
Publicado: (2017)